Schizophrenia evidence

Prabakaran, S., Swatton, J. E.,Ryan, M.M. etal. Mitochondrial dysfunction in schizophrenia evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry, 9 684-697, 2004. 

Davis, K. L., Stewart, D. G., Friedman, J. I. etal. White matter changes in schizophrenia evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 60 443-456,2003. 

Cohen. R.M.. Nordahl, T.E.. Semple, W.E., Pickar. D. The brain metabolic patterns of clozapine- and fhiphenazine-treated female patients with schizophrenia evidence of a sex effect. Neuropsychophannacology 21(5), 632-640, 1999. 

Shelton, R., Karson, C., Doran, A., Pickar, D., Bigelow, L., Weinberger, D. R. (1988). Cerebral structural pathology in schizophrenia Evidence for selective prefrontal cortical defect. American Journal of Psychiatry, 145, 154-163. 

Herken H, Erdal ME. 2001. Catechol-O-methyltransferase gene polymorphism in schizophrenia Evidence for association between symptomatology and prognosis. Psychiatr Genet 11 105-109. 

Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, et al. 2003. Decreased serum levels of D-serine in patients with schizophrenia Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60 572-576. 

Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, et al. 2003. White matter changes in schizophrenia Evidence for myelin-related dysfunction. Arch Gen Psychiatry 60 443-456. 

Johnson SC, Lowery N, Kohler C, Turetsky BI. 2005. Global-local visual processing in schizophrenia Evidence for an early visual processing deficit. Biol Psychiatry 58(12) 937-946. 

Keri S, Antal A, Szekeres G, Benedek G, Janka Z. 2000. Visual information processing in patients with schizophrenia Evidence for the impairment of central mechanisms. Neurosci Lett 293 69-71. 

Keri S, Kelemen O, Janka Z, Benedek G. 2005a. Visual-perceptual dysfunctions are possible endophenotypes of schizophrenia Evidence from the psychophysical investigation of magnocellular and parvocellular pathways. Neuropsychology 19 649-656. 

Martinez A, Hillyard SA, Dias EC, et al. 2008. Magnocellular pathway impairment in schizophrenia Evidence from fMRI. J Neurosci 28(30) 7492-7500. 

Chana G, Landau S, Beasley C, Everall IP, Cotter D. 2003. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia Evidence for decreased neuronal somal size and increased neuronal density Biol Psychiatry 53(12) 1086-1098. 

Sweet RA, Bergen SE, Sun Z, Sampson AR, Pierri JN, et al. 2004. Pyramidal cell size reduction in schizophrenia Evidence for involvement of auditory feedforward circuits. Biol Psychiatry 55(12) 1128-1137. 

Lewis DA, Cruz DA, Melchitzky DS, Pierri JN. 2001. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia Evidence for fewer projections from the thalamus. Am J Psychiatry 158 1411-1422. 

Lewis DA, Glantz LA, Pierri JN, Sweet RA. 2003. Altered cortical glutamate neurotransmission in schizophrenia Evidence from morphological studies of pyramidal neurons. Ann NY Acad Sci 1003 102-112. 

Increased prefrontal and hippocampal glutamate concentration in schizophrenia Evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 58 724-730. 

Alterations of Neurotransmitter Receptors in Schizophrenia Evidence from Postmortem Studies... 

Alterations of neurotransmitter receptors in schizophrenia evidence from postmortem studies... 

---